198 related articles for article (PubMed ID: 30291886)
1. Biglycan gene connects metabolic dysfunction with brain disorder.
Ying Z; Byun HR; Meng Q; Noble E; Zhang G; Yang X; Gomez-Pinilla F
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3679-3687. PubMed ID: 30291886
[TBL] [Abstract][Full Text] [Related]
2. Systems Nutrigenomics Reveals Brain Gene Networks Linking Metabolic and Brain Disorders.
Meng Q; Ying Z; Noble E; Zhao Y; Agrawal R; Mikhail A; Zhuang Y; Tyagi E; Zhang Q; Lee JH; Morselli M; Orozco L; Guo W; Kilts TM; Zhu J; Zhang B; Pellegrini M; Xiao X; Young MF; Gomez-Pinilla F; Yang X
EBioMedicine; 2016 May; 7():157-66. PubMed ID: 27322469
[TBL] [Abstract][Full Text] [Related]
3. Expression of Biglycan in First Trimester Chorionic Villous Sampling Placental Samples and Altered Function in Telomerase-Immortalized Microvascular Endothelial Cells.
Chui A; Gunatillake T; Brennecke SP; Ignjatovic V; Monagle PT; Whitelock JM; van Zanten DE; Eijsink J; Wang Y; Deane J; Borg AJ; Stevenson J; Erwich JJ; Said JM; Murthi P
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1168-1179. PubMed ID: 28408374
[TBL] [Abstract][Full Text] [Related]
4. Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-β1 expression.
Andrlová H; Mastroianni J; Madl J; Kern JS; Melchinger W; Dierbach H; Wernet F; Follo M; Technau-Hafsi K; Has C; Rao Mittapalli V; Idzko M; Herr R; Brummer T; Ungefroren H; Busch H; Boerries M; Narr A; Ihorst G; Vennin C; Schmitt-Graeff A; Minguet S; Timpson P; Duyster J; Meiss F; Römer W; Zeiser R
Oncotarget; 2017 Jun; 8(26):42901-42916. PubMed ID: 28476030
[TBL] [Abstract][Full Text] [Related]
5. Biglycan reduces body weight by regulating food intake in mice and improves glucose metabolism through AMPK/AKT dual pathways in skeletal muscle.
Chung I; Kim SA; Kim S; Lee JO; Park CY; Lee J; Kang J; Lee JY; Seo I; Lee HJ; Han JA; Kang MJ; Lim E; Kim SJ; Wu SW; Oh JY; Chung JH; Kim EK; Kim HS; Shin MJ
FASEB J; 2021 Aug; 35(8):e21794. PubMed ID: 34314059
[TBL] [Abstract][Full Text] [Related]
6. Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.
Tang T; Thompson JC; Wilson PG; Nelson C; Williams KJ; Tannock LR
Connect Tissue Res; 2013; 54(1):5-13. PubMed ID: 22834985
[TBL] [Abstract][Full Text] [Related]
7. HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.
Recktenwald CV; Leisz S; Steven A; Mimura K; Müller A; Wulfänger J; Kiessling R; Seliger B
J Biol Chem; 2012 Jul; 287(29):24320-9. PubMed ID: 22582394
[TBL] [Abstract][Full Text] [Related]
8. Biglycan, a Nitric Oxide-Downregulated Proteoglycan, Prevents Nitric Oxide-Induced Neuronal Cell Apoptosis via Targeting Erk1/2 and p38 Signaling Pathways.
Chen S; Guo D; Zhang W; Xie Y; Yang H; Cheng B; Wang L; Yang R; Bi J; Feng Z
J Mol Neurosci; 2018 Sep; 66(1):68-76. PubMed ID: 30088173
[TBL] [Abstract][Full Text] [Related]
9. UV irradiation-induced production of monoglycosylated biglycan through downregulation of xylosyltransferase 1 in cultured human dermal fibroblasts.
Jin CL; Oh JH; Han M; Shin MK; Yao C; Park CH; Jin ZH; Chung JH
J Dermatol Sci; 2015 Jul; 79(1):20-9. PubMed ID: 25936869
[TBL] [Abstract][Full Text] [Related]
10. Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypes.
Schmitz B; Salomon A; Rötrige A; Ritter M; Ringelstein EB; Fischer JW; Paul M; Brand E; Brand SM
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):871-80. PubMed ID: 23393390
[TBL] [Abstract][Full Text] [Related]
11. Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation.
Ye Y; Hu W; Guo F; Zhang W; Wang J; Chen A
Int J Mol Med; 2012 Nov; 30(5):1075-80. PubMed ID: 22895561
[TBL] [Abstract][Full Text] [Related]
12. Biglycan and chondroitin sulfate play pivotal roles in bone toughness via retaining bound water in bone mineral matrix.
Hua R; Ni Q; Eliason TD; Han Y; Gu S; Nicolella DP; Wang X; Jiang JX
Matrix Biol; 2020 Dec; 94():95-109. PubMed ID: 33002580
[TBL] [Abstract][Full Text] [Related]
13. Biglycan deficiency interferes with ovariectomy-induced bone loss.
Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
[TBL] [Abstract][Full Text] [Related]
14. Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin.
Myren M; Kirby DJ; Noonan ML; Maeda A; Owens RT; Ricard-Blum S; Kram V; Kilts TM; Young MF
Matrix Biol; 2016; 52-54():141-150. PubMed ID: 27072616
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
16. Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2.
Song R; Zeng Q; Ao L; Yu JA; Cleveland JC; Zhao KS; Fullerton DA; Meng X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2711-20. PubMed ID: 22982459
[TBL] [Abstract][Full Text] [Related]
17. Differential metabolic and multi-tissue transcriptomic responses to fructose consumption among genetically diverse mice.
Zhang G; Byun HR; Ying Z; Blencowe M; Zhao Y; Hong J; Shu L; Chella Krishnan K; Gomez-Pinilla F; Yang X
Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165569. PubMed ID: 31669422
[TBL] [Abstract][Full Text] [Related]
18. Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.
Subbarayan K; Massa C; Leisz S; Steven A; Bethmann D; Biehl K; Wickenhauser C; Seliger B
Oncoimmunology; 2022; 11(1):2069214. PubMed ID: 35529675
[TBL] [Abstract][Full Text] [Related]
19. Biglycan promotes hepatic fibrosis through activating heat shock protein 47.
Yu M; He X; Song X; Gao J; Pan J; Zhou T; Wang Q; Zhu W; Ma H; Zeng H; Xu C; Yu C
Liver Int; 2023 Feb; 43(2):500-512. PubMed ID: 36371672
[TBL] [Abstract][Full Text] [Related]
20. Differentiated activities of decorin and biglycan in the progression of post-traumatic osteoarthritis.
Han B; Li Q; Wang C; Chandrasekaran P; Zhou Y; Qin L; Liu XS; Enomoto-Iwamoto M; Kong D; Iozzo RV; Birk DE; Han L
Osteoarthritis Cartilage; 2021 Aug; 29(8):1181-1192. PubMed ID: 33915295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
